Rethinking Oncology Trial Strategy: New Approaches for an Evolving Landscape

Oncology research and development has undergone significant advancements in recent years, with innovative treatment options now offering renewed hope to patients worldwide. This progress is largely driven by emerging biotech companies, which contribute a remarkable 70% of the R&D pipeline.

Drawing from the Global Oncology Trends 2023 report by the IQVIA Institute for Human Data Science, learn how global oncology trends are impacting sponsors and how to optimize clinical trial strategy in the following areas:

• Early phase oncology trial design and strategy
• Platform design trials
• Diversity planning in clinical trial protocols